Roivant Sciences (ROIV) Total Current Liabilities (2021 - 2026)
Roivant Sciences (ROIV) recorded Total Current Liabilities of $283.6 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 149.1% from $113.87 million a year earlier and up 0.8% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Total Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences reported Total Current Liabilities of $281.24 million, up 88.2% from FY2025.
- Annual Total Current Liabilities has a five-year compound annual growth rate of 5.1% (FY2021 to FY2026).
- Across earlier fiscal years, Total Current Liabilities came in at $149.41 million in FY2025 (-44.0%), $266.76 million in FY2024 (-2.1%), $272.45 million in FY2023 (+47.8%) and $184.37 million in FY2022 (-15.8%).
- The fiscal Q1 2027 figure is the highest quarterly Total Current Liabilities since fiscal Q2 2025.
- On a year-over-year basis, Total Current Liabilities has increased for three consecutive quarters, with growth averaging 18.1% over the last eight quarters.
- Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 149.1% in fiscal Q1 2027, against a decline of 75.9% in fiscal Q2 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $281.24 million (Q4 2026), $151.96 million (Q3 2026) and $133.86 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Roivant Sciences | 26.72 Bn | 27.41 Bn | 1.16 Mn | 283.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 283.60 Mn |
| Mar 31, 2026 | 281.24 Mn |
| Dec 31, 2025 | 151.96 Mn |
| Sep 30, 2025 | 133.86 Mn |
| Jun 30, 2025 | 113.87 Mn |
| Mar 31, 2025 | 149.41 Mn |
| Dec 31, 2024 | 141.48 Mn |
| Sep 30, 2024 | 556.25 Mn |
| Jun 30, 2024 | 215.05 Mn |
| Mar 31, 2024 | 266.76 Mn |
| Dec 31, 2023 | 244.90 Mn |
| Sep 30, 2023 | 265.55 Mn |
| Jun 30, 2023 | 245.00 Mn |
| Mar 31, 2023 | 272.45 Mn |
| Dec 31, 2022 | 244.26 Mn |
| Sep 30, 2022 | 230.74 Mn |
| Jun 30, 2022 | 328.92 Mn |
| Mar 31, 2022 | 184.37 Mn |
| Dec 31, 2021 | 160.71 Mn |
| Sep 30, 2021 | 303.44 Mn |
API Access
Roivant Sciences Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();